LXRX
Lexicon Pharmaceuticals Inc
NASDAQ: LXRX · HEALTHCARE · BIOTECHNOLOGY
$2.33
-2.12% today
Updated 2026-06-03
Market cap
$835.09M
P/E ratio
—
P/S ratio
11.99x
EPS (TTM)
$-0.07
Dividend yield
—
52W range
$1 – $3
Volume
2.5M
Lexicon Pharmaceuticals Inc (LXRX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$2.33
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 15.72% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -37.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.